encoded β-O-GlcNAc transferase. We show that the WTA backbone is required for proper cell division, whereas β-O-GlcNAcylation is required to maintain β-lactam resistance in MRSA. Unlike ΔtarO MRSA strains, which are also β-lactam sensitive, ΔtarS strains have no morphological or cell division defects. Hence, the β-lactam susceptibility is not coupled to the global defects in cell division that occur in the absence of WTAs. Through genetic manipulations of WTA tailoring enzymes, we demonstrate that the proper stereochemical linkage of the sugar to the WTA backbone and the C2 N-acetyl substituent are required for the resistant phenotype. Because the structural features required are specific, we speculate that β-O-GlcNAcylated WTAs interact with cell surface factors necessary for β-lactam resistance. We conclude that TarS is a unique possible target for inhibitors to be used in combination with β-lactams to overcome MRSA infections.
Results
Identification of a β-O-GlcNAc Transferase in S. aureus. We recently identified a phage-resistant S. aureus strain, K6, which produces nonglycosylated WTAs (21) . This strain carried a transposon in the tarM gene, and the encoded TarM protein was identified as a WTA α-O-GlcNAc transferase. We subsequently found that a targeted tarM deletion strain, RN4220ΔtarM, is still susceptible to S. aureus serogroup B phages ϕ11, ϕ52A, and ϕ80 ( Fig. 2A) . Because phage infection depends on WTA glycoepitopes (18) , these data suggested that WTAs are glycosylated in the RN4220ΔtarM strain. NMR analysis of WTAs from the ΔtarM strain showed a WTA structure consistent with β-O-GlcNAcylated ribitol phosphate ( Fig. 2 B and C) (24) . Thus, S. aureus strain RN4220 contains a β-O-GlcNAc transferase in addition to the previously identified α-O-GlcNAc transferase. Two putative glycosyltransferase-encoding genes, designated SAOUHSC_00644 and SAOUHSC_00228, were identified in WTA operons of S. aureus NCTC8325 (Fig. S1 ). We used an in vitro reconstitution approach to test their function as WTA β-O-GlcNAc transferases. Each gene was overexpressed as an Nterminal 10-His fusion protein in Escherichia coli and purified by Ni 2+ -affinity chromatography. The poly(RboP)-WTA substrate was synthesized in vitro using a combined chemical and enzymatic approach (Fig. 3A) , and the purified proteins were incubated with this polymer substrate and UDP-[ 14 C]-GlcNAc. Reaction mixtures were separated by PAGE and analyzed using phosphorimaging. No reaction was detectable under any conditions in incubation mixtures containing protein encoded by SAOUHSC_00644, and the function of this protein remains unknown. However, in reactions containing protein encoded by gene SAOUHSC_00228, the radiolabeled sugar starting material disappeared and radiolabeled products having similar mobility to [ 14 C]-WTA polymers appeared (Fig. 3B ). We conclude that SAOUHSC_00228 encodes a WTA glycosyltransferase, which we designated TarS.
TarS Prefers UDP-GlcNAc as a Donor Substrate and Is Specific for Poly (Ribitol Phosphate) WTAs. Most S. aureus strains attach O-GlcNAc to their WTAs, whereas other bacterial strains attach glucose, GalNAc, or other carbohydrates (15) . To examine the donor specificity of TarS, we tested its ability to use four other UDP sugars as donors for glycosylation of poly(RboP)-WTA (Fig. 3B) . The results showed that TarS can use UDP-Glc and UDP-GalNAc as alternative donor substrates, but not UDP-galactose or UDPglucuronic acid. Thus, structural changes at either the C2 or C4 positions of the sugar donor are tolerated, although UDP-GalNAc is a far less efficient substrate than UDP-GlcNAc or UDP-Glc. In TarS reactions incubated with poly(RboP)-WTA and equimolar amounts of UDP-GlcNAc and UDP-Glc, the UDP-GlcNAc peak disappeared, whereas the UDP-Glc peak area was largely unchanged, indicating that UDP-GlcNAc is the preferred donor ( Fig. 3C) .
We tested the ability of TarS to transfer GlcNAc to possible alternate acceptors. Using different combinations of previously characterized WTA biosynthetic enzymes (25) (26) (27) we prepared a WTA pathway intermediate for acceptor testing. CDP ribitol, ribitol phosphate, lipoteichoic acid (LTA), and poly(GroP)-WTA were also tested as acceptor substrates. No glycosylation of any of these substrates was observed ( Fig. 3D and Fig. S2 ), showing that TarS is specific for substrates containing multiple RboP units. These data support the prediction that WTA glycosylation in S. aureus, as in Bacillus subtilis (28) , occurs after polymer synthesis is complete.
TarS β-O-GlcNAcylates WTAs in S. aureus Cells. To investigate the function of TarS in cells, we deleted tarS from wild-type RN4220 and the RN4220ΔtarM strain and checked susceptibility of the mutants to phages ϕ11, ϕ52A, and ϕ80. The ΔtarS strain was as susceptible to the test phage as the parental and ΔtarM strains, but the ΔtarMΔtarS double mutant was phage resistant ( Fig. 2A) . To establish the anomeric stereochemistry of the TarS product, we extracted WTAs (25) from the deletion strains and analyzed NMR spectra of their monomer units. β-O-GlcNAcylated ribitol phosphates have an anomeric β-O-GlcNAc 1 H resonance at 4.73 ppm and a 13 C resonance at 101.6 ppm (24). This peak is absent in WTAs extracted from the ΔtarMΔtarS strain, but is present in WTAs from the ΔtarM strain and the ΔtarMΔtarS strain expressing TarS from a plasmid ( Fig. 2 B and C and Fig. S3 ). Thus, TarS β-O-GlcNAcylates WTAs in S. aureus.
The WTA Polymer Backbone, but Not Its Tailoring Modifications, Is
Essential for Properly Regulated Cell Division. WTA null (ΔtarO) strains have several phenotypes. They are temperature sensitive, reach stationary phase at a lower density than wild-type strains, undergo Triton-X-induced autolysis at an increased rate, and show increased susceptibility to lysostaphin (13, 14) . Perhaps more striking, the absence of WTAs results in massively dysregulated cell division and sensitizes MRSA to β-lactams (11) . To correlate phenotypes observed in S. aureus WTA null strains with particular WTA structural features, we deleted dltA, tarM, and tarS singly and in combination from S. aureus MW2, a well-characterized community-acquired MRSA strain (29) that produces similar amounts of αand β-O-GlcNAcylated WTAs. Deleting dltA prevents attachment of D-alanyl esters to both lipo-and wall teichoic acids (15) . Deleting tarM results in the expression of only β-O-GlcNAcylated WTAs, deleting tarS leads to the production of only α-O-GlcNAcylated WTAs, and deleting both genes results in unglycosylated WTAs (Fig. S4A ).
Several phenotypes of the deletion strains were examined and it was found that deletion of the O-GlcNAc transferase genes alone or in combination had a negligible effect on cell growth rates, in vitro fitness, autolysin activation, lysostaphin susceptibility, and biofilm formation ( Fig. S5 ). In contrast, preventing D-alanylation led to several phenotypes that are also observed in the ΔtarO strain, either herein or in previous publications, including a decreased growth rate, increased Triton-X-induced autolysis, and decreased biofilm formation, consistent with previous studies on other ΔdltA strains (17, 30) .
To determine whether any of the WTA substituents play a role in regulating cell division, we compared transmission electron microscopy (TEM) images of the mutant strains to those of the wild-type and ΔtarO strains. Whereas the MW2ΔtarO strain showed defects in septal placement and daughter cell separation, none of the other mutant strains, including the triple mutant lacking all WTA decorations, displayed any septal abnormalities ( Fig. 4A and Fig. S6 ). Hence, the cell division defects observed in ΔtarO strains are not due to the absence of a tailoring modification, but to the absence of the anionic poly(RboP) backbone.
WTA β-O-GlcNAc Modifications Are Required to Maintain β-Lactam
Resistance in MRSA. Because preventing WTA expression sensitizes MRSA strains to β-lactams by an unknown mechanism (11), we measured β-lactam minimum inhibitory concentrations (MICs) for the MW2 deletion strains to determine whether any tailoring modifications were required for resistance. Other antibiotics were included as controls ( Fig. 4B and Fig. S7A ). As observed previously, the ΔdltA strain was more sensitive to cationic antibiotics than wild-type S. aureus, perhaps because the increased negative surface charge density attracts cationic molecules. This strain also showed reduced MICs for methicillin and imipenem, but unlike the ΔtarO strain, it was not more susceptible to several other β-lactams. The ΔtarM strain showed no change in sensitivity to any antibiotics. In striking contrast however, the ΔtarS strain showed increased susceptibility to the same set of β-lactams as the ΔtarO strain, but not to any other antibiotics, including other cell- wall-active antibiotics. Complementation of MW2ΔtarMΔtarS with a plasmid expressing catalytically active TarS restored wild-type resistance levels, whereas complementation with a plasmid expressing TarM or a catalytically inactive variant of TarS did not (Figs. S4B and S7 B and C). These results established that the sensitized phenotype of the tarS deletion strains is not due to polar effects, but to the lack of a functional WTA β-O-GlcNAc transferase. Consistent with the importance of tarS in mediating resistance, its expression was fourfold up-regulated in the presence of β-lactams, whereas the expression of tarM was unchanged ( Fig. S8A ). QRT-PCR analysis showed that expression of the gene encoding the β-lactam resistant transpeptidase PBP2a, mecA, was unaffected by tarS deletion, indicating that sensitivity is not due to down-regulation of the resistance determinant. Expression levels of several other genes implicated in β-lactam resistance, including pbp4 and fmtA, were also unaffected ( Fig. S8B ). Taken together, these results are consistent with a direct role for β-O-GlcNAcylated WTAs in maintaining β-lactam resistance.
To obtain further information on the structural requirements of the WTA sugar residue in resistance, we sought to replace β-O-GlcNAc with another β-linked sugar. B. subtilis W23 makes poly(RboP)-WTAs containing β-O-glucose WTA modifications (31) , but the tailoring enzyme had not been identified. There are four predicted glycosyltransferases, tarEMNQ, in the W23 WTA gene cluster. Since TarQ has the highest homology to TarS, we constructed two B. subtilis W23 strains, one containing a marked deletion of tarQ (W23ΔtarQ) and the other containing an additional deletion of genes tarEMN (W23ΔQΔtarEMN). Quadrupole (Q)TOF-MS analysis of extracted WTAs showed that glucosylation was absent in both mutant strains ( Fig. S9A ). Because deletion of tarQ was sufficient to abolish glucosylation, we concluded that TarQ is the primary WTA β-O-glucosyl transferase in B. subtilis W23. The tarQ gene was therefore expressed from a plasmid in MW2ΔtarMΔtarS, and this tarQ expression strain was shown to produce WTAs modified with glucose ( Fig. S9B ). However, unlike strains expressing tarS from a plasmid, this strain was not resistant to β-lactams ( Fig. S7C ). The resistance phenotype thus depends not only on the β-anomeric configuration of the WTA sugar modification, but also on the presence of a C2 N-acetyl moiety ( Fig. 4C ). Hence, the structural features required for resistance are specific, suggesting that β-O-GlcNAcylated WTAs establish selective interactions with other cell surface factors required for resistance.
To determine whether β-O-GlcNAcylated WTAs play a role in β-lactam resistance in other MRSA strains, we deleted tarS from four additional community-and hospital-acquired MRSA strains and measured their β-lactam MICs. These tarS deletion strains were also sensitized to β-lactams ( Fig. S7D ), implying that β-O-GlcNAcylated WTAs are a general resistance factor in MRSA strains. Accordingly, TarS is a possible target for small molecules that sensitize MRSA to β-lactams. Fig. 2 . TarS is a β-O-GlcNAc-WTA transferase in vivo. (A) Soft agar assay for phage susceptibility of RN4220 wild type, ΔtarM, ΔtarS, ΔtarMΔtarS, and the double mutant complemented with tarS (ΔtarMΔtarSPtarS). The double mutant, ΔtarMΔtarS, leads to resistance to serogroup B phages ϕ52A, ϕ11, and ϕ80. Mutation 201A, leading to a truncated tarS gene, was identified in the previously reported strain K6. This explains previous findings (21) that this strain, which contains a transposon insertion in tarM, is completely phage resistant. (B) 1 H NMR spectra of chemically extracted and degraded WTA monomers from the RN4220 ΔtarM, ΔtarMΔtarS, and ΔtarMΔtarS P cad tarS strains (D 2 O; Varian; 400 mHz). Arrow points to the H-1 proton of the β-O-GlcNAc residue on ribitol phosphate. Peak corresponding to the amide of the C2 N-acetyl group attached to the sugar is identified as NHAc. Both the single knockout and the tarS-complemented strain produce β-O-GlcNAcylated WTAs, but the double knockout does not. (Fig. S3 ) (C) Heteronuclear 13 C, 1 H single quantum correlation (HSQC) of the WTA monomer from the RN4220 ΔtarM strain. The H-1 proton of the β-O-GlcNAc residue is indicated by the arrow and confirms the signal at δ4.73 is indicative of a β-O-GlcNAcribitol-phosphate WTA monomer. These NMR data correlate with previous NMR analyses of β-O-GlcNAc-ribitol-phosphate WTA monomers (21, 24) .
TarS Is Required for Oxacillin Resistance in a Caenorhabditis elegans
Model. The bacterivorous nematode C. elegans dies upon ingestion of pathogenic S. aureus, and is commonly used as a simple model host to evaluate the virulence of different bacterial strains in the presence and absence of antibiotics (32, 33) . Using this host, we evaluated the virulence of MW2ΔtarS compared with wild type, and determined bacterial susceptibility to treatment with oxacillin in vivo by evaluating nematode survival over time (Fig. S10 ). In the absence of antibiotic, the MW2ΔtarS strain was slightly attenuated compared with wild type, suggesting a modest role for the β-O-GlcNAc WTA moieties in pathogenesis in this system. At the highest tested dose, oxacillin partially rescued nematodes infected with wild-type MW2. In contrast, at the lowest dose tested, the antibiotic completely rescued animals infected with MW2ΔtarS. We conclude that β-O-GlcNAcylation of WTAs plays an important role in β-lactam resistance in vivo as it does in vitro.
Discussion
WTAs play an important role in regulating cell division in S. aureus and are also involved in maintaining resistance to β-lactams in MRSA strains (11) . In this paper, we used biochemical and genetic approaches to examine the roles of the WTA polymer backbone and three tailoring modifications in these important phenotypes. We showed that the polymer backbone alone is required for properly regulated cell division because deletion of all three tailoring genes did not affect septal placement or cell separation. We also showed that a single WTA tailoring modification, β-O-GlcNAcylation, mediated by a newly discovered glycosyltransferase named TarS, is required to maintain wild-type levels of β-lactam resistance.
The mechanism by which β-O-GlcNAcylated WTAs confer resistance to β-lactams in MRSA is not yet known. TarS deletion does not cause apparent growth or cell division defects and its deletion does not down-regulate expression of mecA or other tested genes implicated in β-lactam resistance. MRSA β-lactam resistance cannot be suppressed by expressing glycosyltransferases that incorporate either α-O-GlcNAcs or β-O-glucose residues into WTAs. Because the susceptibility phenotype seems directly attributable to the absence of the β-O-GlcNAc modifications on WTAs, we propose a scaffolding role for β-O-GlcNAcylated WTAs in methicillin resistance. Consistent with this hypothesis, it has been previously speculated that WTAs can scaffold PG synthesis and degradation proteins (11, (34) (35) (36) . Moreover, a recent paper has shown that both PBP2a and FmtA directly bind WTAs in vitro (37). Polyvalent scaffolding by glycopolymers (glycolipids and glycoproteins) is a known mechanism for organizing proteins in a variety of biological processes (38, 39) . Whereas there are no genes of high homology to tarS in Staphylococcus sciuri, the organism from which PBP2a was speculated to derive (40, 41) , all deposited S. aureus strain sequences in the National Center for Biotechnology Information contain tarS. It is possible that PBP2a may exploit β-O-GlcNAcylated WTAs by binding to them directly or by interacting with other cellular factors that are scaffolded by these polymers. There are many genes native to S. aureus that have been shown to play a role in maintaining β-lactam resistance (7-10), including genes encoding proteins with extracellular domains that could interact with β-O-GlcNAc WTA tailoring modifications.
In closing, we note that there is considerable interest in compounds that restore β-lactam sensitivity to resistant microorganisms (42) . Because β-lactam resistance in MRSA involves a resistant transpeptidase that depends on the function of other cellular factors for activity (4) (5) (6) , compound combinations that target the activity of these other factors could be useful for overcoming MRSA infections. β-lactamase inhibitors have been highly successful as components of compound combinations to treat many β-lactam-resistant infections (2, 3). Because deletion of the tarS gene sensitizes MRSA to β-lactams, we propose that TarS is a unique target for compounds used in combination with β-lactams to treat MRSA infections.
Materials and Methods
The bacterial strains, plasmids, and primers for PCR amplification are listed in Table S1 . More detailed methods can be found in SI Materials and Methods.
Cloning, Overexpression, and Purification of SAOUHSC_00228 and SAOUHSC_00644. Genes were PCR amplified from RN4220 DNA ligated into a pET-47b(+) vector (Novagen), which had been modified to a cleavable N-terminal His-tag with 10-His residues transformed into Rosetta2(DE3)pLysS cells for overexpression by isopropyl-β-D-1-thiogalactopyranoside (IPTG) at 16°C. The cell pellet was resuspended in 50 mM Tris·HCl pH 8, 200 mM NaCl, 0.1% Tween-20, and 25% (vol/vol) glycerol, benzonase, and rLysozyme (Novagen) was added and the cells sonicated. The clarified lysate was purified using nickel resin. Purified protein was stored as 50% (vol/vol) glycerol stocks at either −20°C or −80°C. The yield is ∼5 mg/L for SAOUHSC_00228 and 33 mg/L for SAOUHSC_00644. 700 μM CDP-glycerol, 20 mM Tris pH 8, 5 mM MgCl2, 500 nM TagF, 10 μM 228 or 130 μM 644, 7 μM [ 14 C]-UDP-GlcNAc, and 63μM UDP sugar. As a control to ensure TagF activity, the reaction was also set up in the same manner except with the addition of 21 μM CDP-[ 14 C]-glycerol and cold UDP-GlcNAc. Reactions testing LTA (Sigma) were set up in a similar manner except TagF and CDP-glycerol were omitted. As a negative control, identical reactions were set up using heat-treated enzyme. After 2 h at room temperature the reactions were quenched with an equal volume of dimethylformamide and analyzed by gel electrophoresis and phosphorimaging.
Construction of Deletion Strains. B. subtilis W23 was transformed with linear DNA harboring a resistance cassette flanked by 1,000 bp of DNA upstream and downstream of the targeted genes (25) . The RN4220 tarS gene was deleted using the pKOR1 vector, whereas, all other S. aureus gene deletions were made using the pMAD plasmid. The ΔdltA strain is identical to that which was published previously (16) . For MW2 deletions, the plasmid was first passaged through RN4220. The tarS/tarM deletion strains were back complemented with TarS by cloning the gene into the pLI50-P cadC shuttle expression vector under the control of a cadmium-inducible promoter. The D92A, D94A inactive TarS point mutant was made using the QuikChange Lightning (Agilent) kit according to the manufacturer's instructions. ]-glucuronic acid is from MP Biomedicals. All other reagents and chemicals were obtained from VWR and Sigma. RNA isolation and QRT-PCR was performed as described previously (3) using the listed QRT-PCR primers. The procedure for wall teichoic acid (WTA) isolation, chemical degradation, and mass spectrometry analysis has been described previously (4) . Radioactive labeling was performed as described previously (5) (6) (7) (8) . The preparation of images for transmission electron microscopy was followed as described previously (9) . Minimum inhibitory concentration (MIC) values were obtained as described previously (9) . Bacillus subtilis W23 was grown in LB broth and Staphylococcus aureus strains were grown in tryptic soy broth unless otherwise indicated. For S. aureus plasmids, antibiotic markers were selected with 10 or 30 μg/mL erythromycin and 10 or 50 μg/mL chloramphenicol. For B. subtilis W23 transformants were selected using 5 μg/mL chloramphenicol and 100 μg/mL spectinomycin.
Supporting Information
Cloning and Overexpression of TagF from B. subtilis 168. TagF was cloned and overexpressed as reported previously following some modifications (10) . TagF was PCR amplified from B. subtilis PY79 genomic DNA using the primers listed ligated into pET-24b(+) and the construct was transformed into Rosetta2(DE3) pLysS. Cells were grown to midlog phase and induced with 1 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG). The culture was allowed to grow overnight at 16°C. The cell pellet was resuspended in lysis buffer consisting of 100 mM Tris·HCl pH 7.5, 500 mM NaCl, 0.6% CHAPS, and 20% (vol/vol) glycerol. Benzonase and rlysozyme were used to lyse the cells. The clarified lysate was purified by nickel chromatography. The purified fraction was further purified in the same lysis buffer without glycerol using a Superdex 200 10/300 GL gel filtration column (GE Healthcare). The purified product eluted as both a monomer and aggregate. The aggregate fraction was used for in vitro reactions. The final yield of aggregate protein was ∼0.1 mg/L and this protein was stored at −20°C in 50% (vol/vol) glycerol.
Lipid-WTA Substrate Preparation. Farnesyl-PP-GlcNAc-ManNAc-GroP-RboP, neryl-PP-GlcNAc-ManNac-[ 14 C]-GroP-[ 14 C]-GroPpoly(RboP), ribitol-5-phosphate, and CDP-ribitol were prepared and purified as described previously (4) . The WTA polymer lipid was purified using weak anion exchange column from Phenomenex (Strata X 33 μm Polymeric Weak Anion 100 mg/3 mL). The column was prepared by washing with 2 mL of methanol followed by 2 mL of water. A 40 μL, 40 μM lipid reaction was applied to the column, washed with 3 mL methanol plus 1% (vol/vol) NH4OH, then the product was eluted with 3 mL MeOH + 5% (vol/vol) NH4OH. In Vivo Growth Competition. MW2 strains GFP and mCherry strains were grown overnight at 37°C in tryptic soy broth (TSB). They were diluted 1:1,000 into fresh TSB in the same tube, grown at 37°C with shaking, and then plated on TSB/agar after 14 h. Cultures were supplemented with 10 μg/mL chloramphenicol to retain the plasmid. These experiments were performed in biological and analytical duplicate.
Biofilm Analysis. Biofilm assays were performed using previously developed protocols (11) (12) (13) (14) (15) . Cultures were grown overnight at 37% in TSB + 0.25% glucose and then diluted 1:200 into the same media. Two-hundred microliters of cells were put into 96well flat bottom tissue culture-treated polystyrene plates (Corning; 3595). The samples were plated in five replicates in two different plates with a row of blank TSB between each strain. Plates were left for 24 h without shaking at 37°C. The cultures were dumped and washed vigorously three times with 100 μL PBS. The plate was dried completely at 65°C. Two-hundred microliters of ethanol was added and the plates sat for 1 min. Ethanol was removed, 200 μL 0.1% safranin was added, and the plates were incubated at room temperature for 10 min. After removing the stain, the wells were washed four times with 100 μL PBS and dried completely at 65°C. Two-hundred microliters of ethanol was added and the plates were shaken at room temperature for 10 min. Finally the absorbance (OD 450 ) was read.
Autolysis. Cell autolysis rates were determined as described previously (11, 16) . Briefly, cells were grown to midexponential phase, washed twice in 10 mM sodium phosphate buffer pH 7, and then once with ice-cold water. Cells were resuspended in 10 mM sodium phosphate buffer with 0.05% Triton X-100, and autolysis was recorded at 37°C without shaking by monitoring the decrease in OD 600 . NMR Spectroscopy. NMR spectra were recorded at 25°C in D 2 O on a Varian 400 instrument, using DSS as reference (1H, δ 0 ppm).
Nematode Killing Assays. Infertile spe-9; fer-15 Caenorhabditis elegans were grown on nematode growth medium seeded with nonpathogenic Escherichia coli OP50, as previously described (17) . Synchronized L4 larvae were transferred to TSA plates seeded with MW2 or MW2 ΔtarS and incubated at 25°C, as previously described (17) . Assays were performed in technical triplicates and biological duplicates. Equal volumes of oxacillin solution or sterile water were added at 17 h after infection initiation. Survival was scored over time as indicated (17) . Statistical analysis was performed using Prism 5 (Graphpad) and the log-rank method comparing mutant vs. wild type MW2. P ≤ 0.01 was considered significant. Fig. S1 . Genetic organization of S. aureus RN4220 wall teichoic acid biosynthetic genes. Double hash mark (//) within the operon denotes more than 500 bp between genes. SAOUHSC_00228 and SAOUHSC_00644 were predicted to encode glycosyltransferases and were overexpressed and assayed for activity as shown in Fig. 3A . monomers (1, 2) . The HSQC for RN4220ΔtarM is presented in Fig. 2C . P1Tar228 A ntibiotics have provided arguably the greatest benefit to human health among developments of the past century, and so the emergence of widespread antibiotic resistance is now a grave threat to 21stcentury health (1). Among antibioticresistant organisms, methicillin-resistant Staphylococcus aureus (MRSA) emerged early and presents one of the most serious challenges, a situation compounded by the extension of its range from being primarily a nosocomial problem to include community-acquired and livestock-associated spread (2, 3) . Novel strategies to combat MRSA are therefore urgently needed, and so it is notable that, in PNAS, Brown et al. (4) have identified a surprising chink in the bacterial armor that may allow the development of novel therapeutic strategies to target MRSA.
β-Lactam antibiotics such as methicillin target the penicillin-binding proteins that form the peptide cross-links that provide structural integrity to the peptidoglycan, the uniquely bacterial polymer of the cell wall. MRSA strains emerge when methicillin-susceptible S. aureus (MSSA) acquires the mecA gene through lateral gene transfer on the staphylococcal chromosomal cassette mecA, which encodes a lowaffinity penicillin-binding protein, PBP2a, which is insensitive to penicillin and to many other β-lactam antibiotic agents (3, 5) . However, the robustness of the MRSA phenotype is modulated by many other aspects of the MSSA strain background that acquires mecA (6). The complexity of the MRSA phenotype thus offers hope that drug interactions and other interventions can be devised that will allow the restoration of an MSSA phenotype to MRSA strains (7) (8) (9) . The work of Brown et al. (4) identifies a significant target that may be exploited to allow resensitization of MRSA.
Teichoic Acid Biosynthesis Affects the MRSA Phenotype
Gram-positive bacteria such as S. aureus lack outer membranes but have relatively thick cell walls. In addition to the peptidoglycan component, these cell walls also typically contain a covalently integrated cell wall polymer that, in many cases, is a teichoic acid (TA) (10, 11) . TAs are structurally diverse polyanionic polymers that include alditol-phosphates in their repeating units. In S. aureus, the TAs are polymers of ribitol-phosphate that are decorated with several substituents including β-O-N-acetyl-D-glucosamine (β-O-GlcNac) (4). Building on their earlier observation that inhibition of the first step in TA biosynthesis resensitized MRSA to β-lactams (9), Brown et al. (4) elegantly define the precise aspect of TA structure that modulates this susceptibility.
As part of their ongoing investigations of the TA biosynthesis pathway, Brown et al. (4) screened the genetic loci associated with TA biosynthesis in the S. aureus genome for glycosyltransferases that might
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identifies a significant target that may be exploited to allow resensitization of MRSA. be involved in TA decoration. By using an in vitro assay facilitated by their ability to synthesize the poly(ribitol-phosphate) substrate, they identify one candidate glycosyltransferase as a β-O-GlcNac transferase capable of modifying the TA backbone. Additional biochemical characterization confirmed the specificity of the reaction, allowing the gene encoding the glycosyltransferase, SAOUHSC_00228, to be redesignated tarS. Generation of mutant strains lacking tarS confirmed its functionality as a TA β-O-GlcNac transferase.
By using a TA null mutant (9) in comparison with a panel of S. aureus strain MW2 mutants lacking specific decorations of the TA, Brown et al. (4) are able to dissect out the contribution of different TA structural features to various phenotypes associated with TA function. Most strikingly, they convincingly demonstrate that it is the TarS-mediated β-O-GlcNac modification of the TA that influences the MRSA phenotype. The TA null mutant and tarS deletion mutant showed decreased minimum inhibitory concentrations (i.e., increased sensitivity, typically at least fourfold) to a panel of six β-lactam antibiotics. As expected, complementation with tarS reversed this increase in sensitivity, whereas complementation with an inactivated mutant tarS allele did not. Moreover, complementation with the gene (tarM) encoding the S. aureus enzyme that modifies the TA with α-O-GlcNac or a gene encoding a Bacillus subtilis β-Oglucosyl transferase confirmed that the effect of TA modification on the MRSA phenotype was specific to the β-O-GlcNac modification.
Reversing Resistance can Prolong Antibiotic Utility
The work of Brown et al. (4) thus strongly implicates TarS as a potential new target, inhibition of which could resensitize MRSA to β-lactam antibiotic agents. Restoration of antibiotic sensitivity to resistant strains, thereby reviving the effectiveness of an established antibiotic agent, is an attractive proposition given the welldocumented "innovation gap" in the development of novel antibiotic agents (1). The utility of this approach is already evidenced by the well-established use of β-lactamase inhibitors to allow the continued use of β-lactam antibiotic agents in situations in which strains would be otherwise resistant to β-lactams through the production of β-lactamases (12) .
The mechanism by which TarS modulates the MRSA phenotype is also of interest, especially as the precise functions of TA still remain elusive (11) . Whereas TA null mutants are defective in cell division (4, 9) , tarS and tarM mutants (and a tarS tarM double mutant) of S. aureus MW2 are not (4). Brown et al. (4) plausibly speculate that modification of S. aureus TA with β-O-GlcNac may influence its ability to act as a scaffold for cell envelope associated proteins, and that this directly or indirectly modulates PBP2a activity. However, it also likely that TA modifications with sugars and/or D-alanine will impact on the biophysical properties of the peptidoglycan matrix by affecting its packing and influencing the overall cell wall milieu. In this regard, it is notable that a recent study shows that the D-alanine modification of membrane-anchored lipo-TA (LTA), which is directly comparable to D-alanine modification of TA, affects the packing density of the cell wall of group B Streptococcus (13) . Intriguingly, D-
